Central cardiovascular action of urotensin II in spontaneously hypertensive rats

Yingzi Lin, Takuya Tsuchihashi, Kiyoshi Matsumura, Masayo Fukuhara, Yusuke Ohya, Koji Fujii, Mitsuo Iida

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

We have previously reported that urotensin II acts on the central nervous system to increase blood pressure in normotensive rats. In the present study, we have determined the central cardiovascular action of urotensin II in spontaneously hypertensive rats (SHR). Intracerebroventricular (ICV) injection of urotensin II elicited a dose-dependent increase in blood pressure in both SHR and normotensive Wistar-Kyoto rats (WKY). The changes in mean arterial pressure induced by ICV urotensin II at doses of 1 and 10 nmol in the WKY were 8±2 and 23±3mmHg, respectively. ICV administration of urotensin II caused significantly greater, increases in blood pressure in SHR (16±3 mmHg at 1 nmol and 35±3 mmHg at 10 nmol, respectively) compared with those in WKY. Urotensin II (10 nmol) elicited significant and comparable increases in heart rate in SHR (107± 10 bpm) and WKY (101±21 bpm). Plasma epinephrine concentrations after ICV administration of 10 nmol urotensin II were 203±58 pmol/ml in SHR and 227±47 pmol/ml in WKY, which tended to be higher than those in artificial cerebrospinal fluid-injected rats (73±7 and 87±28 pmoVml, respectively, p<0.1). The immunore-activity of urotensin II receptor GPR 14 was expressed extensively in the glial cells within the brainstem, hypothalamus, and thalamus. These results suggest that central urotensin II may play a role in the pathogenesis of hypertension in SHR. Since GPR 14 was expressed in the glial cells of the brain, urotensin II may act as a neuromodulator to regulate blood pressure.

Original languageEnglish
Pages (from-to)839-845
Number of pages7
JournalHypertension Research
Volume26
Issue number10
DOIs
Publication statusPublished - Oct 1 2003

Fingerprint

Inbred SHR Rats
Inbred WKY Rats
Blood Pressure
Neuroglia
urotensin II
Thalamus
Epinephrine
Hypothalamus
Brain Stem
Neurotransmitter Agents
Cerebrospinal Fluid
Arterial Pressure
Central Nervous System
Heart Rate
Hypertension
Injections
Brain

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Lin, Y., Tsuchihashi, T., Matsumura, K., Fukuhara, M., Ohya, Y., Fujii, K., & Iida, M. (2003). Central cardiovascular action of urotensin II in spontaneously hypertensive rats. Hypertension Research, 26(10), 839-845. https://doi.org/10.1291/hypres.26.839

Central cardiovascular action of urotensin II in spontaneously hypertensive rats. / Lin, Yingzi; Tsuchihashi, Takuya; Matsumura, Kiyoshi; Fukuhara, Masayo; Ohya, Yusuke; Fujii, Koji; Iida, Mitsuo.

In: Hypertension Research, Vol. 26, No. 10, 01.10.2003, p. 839-845.

Research output: Contribution to journalArticle

Lin, Y, Tsuchihashi, T, Matsumura, K, Fukuhara, M, Ohya, Y, Fujii, K & Iida, M 2003, 'Central cardiovascular action of urotensin II in spontaneously hypertensive rats', Hypertension Research, vol. 26, no. 10, pp. 839-845. https://doi.org/10.1291/hypres.26.839
Lin Y, Tsuchihashi T, Matsumura K, Fukuhara M, Ohya Y, Fujii K et al. Central cardiovascular action of urotensin II in spontaneously hypertensive rats. Hypertension Research. 2003 Oct 1;26(10):839-845. https://doi.org/10.1291/hypres.26.839
Lin, Yingzi ; Tsuchihashi, Takuya ; Matsumura, Kiyoshi ; Fukuhara, Masayo ; Ohya, Yusuke ; Fujii, Koji ; Iida, Mitsuo. / Central cardiovascular action of urotensin II in spontaneously hypertensive rats. In: Hypertension Research. 2003 ; Vol. 26, No. 10. pp. 839-845.
@article{352cdfa4aaed45bb8971a40e313dc64e,
title = "Central cardiovascular action of urotensin II in spontaneously hypertensive rats",
abstract = "We have previously reported that urotensin II acts on the central nervous system to increase blood pressure in normotensive rats. In the present study, we have determined the central cardiovascular action of urotensin II in spontaneously hypertensive rats (SHR). Intracerebroventricular (ICV) injection of urotensin II elicited a dose-dependent increase in blood pressure in both SHR and normotensive Wistar-Kyoto rats (WKY). The changes in mean arterial pressure induced by ICV urotensin II at doses of 1 and 10 nmol in the WKY were 8±2 and 23±3mmHg, respectively. ICV administration of urotensin II caused significantly greater, increases in blood pressure in SHR (16±3 mmHg at 1 nmol and 35±3 mmHg at 10 nmol, respectively) compared with those in WKY. Urotensin II (10 nmol) elicited significant and comparable increases in heart rate in SHR (107± 10 bpm) and WKY (101±21 bpm). Plasma epinephrine concentrations after ICV administration of 10 nmol urotensin II were 203±58 pmol/ml in SHR and 227±47 pmol/ml in WKY, which tended to be higher than those in artificial cerebrospinal fluid-injected rats (73±7 and 87±28 pmoVml, respectively, p<0.1). The immunore-activity of urotensin II receptor GPR 14 was expressed extensively in the glial cells within the brainstem, hypothalamus, and thalamus. These results suggest that central urotensin II may play a role in the pathogenesis of hypertension in SHR. Since GPR 14 was expressed in the glial cells of the brain, urotensin II may act as a neuromodulator to regulate blood pressure.",
author = "Yingzi Lin and Takuya Tsuchihashi and Kiyoshi Matsumura and Masayo Fukuhara and Yusuke Ohya and Koji Fujii and Mitsuo Iida",
year = "2003",
month = "10",
day = "1",
doi = "10.1291/hypres.26.839",
language = "English",
volume = "26",
pages = "839--845",
journal = "Hypertension Research",
issn = "0916-9636",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Central cardiovascular action of urotensin II in spontaneously hypertensive rats

AU - Lin, Yingzi

AU - Tsuchihashi, Takuya

AU - Matsumura, Kiyoshi

AU - Fukuhara, Masayo

AU - Ohya, Yusuke

AU - Fujii, Koji

AU - Iida, Mitsuo

PY - 2003/10/1

Y1 - 2003/10/1

N2 - We have previously reported that urotensin II acts on the central nervous system to increase blood pressure in normotensive rats. In the present study, we have determined the central cardiovascular action of urotensin II in spontaneously hypertensive rats (SHR). Intracerebroventricular (ICV) injection of urotensin II elicited a dose-dependent increase in blood pressure in both SHR and normotensive Wistar-Kyoto rats (WKY). The changes in mean arterial pressure induced by ICV urotensin II at doses of 1 and 10 nmol in the WKY were 8±2 and 23±3mmHg, respectively. ICV administration of urotensin II caused significantly greater, increases in blood pressure in SHR (16±3 mmHg at 1 nmol and 35±3 mmHg at 10 nmol, respectively) compared with those in WKY. Urotensin II (10 nmol) elicited significant and comparable increases in heart rate in SHR (107± 10 bpm) and WKY (101±21 bpm). Plasma epinephrine concentrations after ICV administration of 10 nmol urotensin II were 203±58 pmol/ml in SHR and 227±47 pmol/ml in WKY, which tended to be higher than those in artificial cerebrospinal fluid-injected rats (73±7 and 87±28 pmoVml, respectively, p<0.1). The immunore-activity of urotensin II receptor GPR 14 was expressed extensively in the glial cells within the brainstem, hypothalamus, and thalamus. These results suggest that central urotensin II may play a role in the pathogenesis of hypertension in SHR. Since GPR 14 was expressed in the glial cells of the brain, urotensin II may act as a neuromodulator to regulate blood pressure.

AB - We have previously reported that urotensin II acts on the central nervous system to increase blood pressure in normotensive rats. In the present study, we have determined the central cardiovascular action of urotensin II in spontaneously hypertensive rats (SHR). Intracerebroventricular (ICV) injection of urotensin II elicited a dose-dependent increase in blood pressure in both SHR and normotensive Wistar-Kyoto rats (WKY). The changes in mean arterial pressure induced by ICV urotensin II at doses of 1 and 10 nmol in the WKY were 8±2 and 23±3mmHg, respectively. ICV administration of urotensin II caused significantly greater, increases in blood pressure in SHR (16±3 mmHg at 1 nmol and 35±3 mmHg at 10 nmol, respectively) compared with those in WKY. Urotensin II (10 nmol) elicited significant and comparable increases in heart rate in SHR (107± 10 bpm) and WKY (101±21 bpm). Plasma epinephrine concentrations after ICV administration of 10 nmol urotensin II were 203±58 pmol/ml in SHR and 227±47 pmol/ml in WKY, which tended to be higher than those in artificial cerebrospinal fluid-injected rats (73±7 and 87±28 pmoVml, respectively, p<0.1). The immunore-activity of urotensin II receptor GPR 14 was expressed extensively in the glial cells within the brainstem, hypothalamus, and thalamus. These results suggest that central urotensin II may play a role in the pathogenesis of hypertension in SHR. Since GPR 14 was expressed in the glial cells of the brain, urotensin II may act as a neuromodulator to regulate blood pressure.

UR - http://www.scopus.com/inward/record.url?scp=0242441544&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242441544&partnerID=8YFLogxK

U2 - 10.1291/hypres.26.839

DO - 10.1291/hypres.26.839

M3 - Article

VL - 26

SP - 839

EP - 845

JO - Hypertension Research

JF - Hypertension Research

SN - 0916-9636

IS - 10

ER -